Ani Pharmaceuticals reported $191.38M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Aerie Pharmaceuticals AERI:US $ 355.65M 79.7M
Aurora Cannabis Inc ACB:CN 604.44M 48.57M
Canopy Growth Corp WEED:CN C$ 1.99B 514.85M
Depomed DEPO:US $ 112.54M 6.8M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Omeros OMER:US $ 210.22M 37.67M
Teva Pharmaceutical TEVA:IT 12.57B 419M